Morphine (Chlorhydrate) Aguettant (Morphine Hydrochloride)

Morphine, the active ingredient in Morphine (Chlorhydrate) Aguettant, is an opioid analgesic presented as an injectable solution for intravenous or subcutaneous use. It treats severe acute pain, postoperative pain, and cancer‑related pain in adult patients.

GNH USA supplies Morphine (Chlorhydrate) Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine is an opioid analgesic used to manage severe pain conditions.

- Severe acute pain: provides rapid relief of intense, breakthrough pain. - Postoperative pain: controls pain following surgical procedures. - Cancer‑related pain: alleviates chronic malignant pain and improves quality of life.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: feeling of sickness that may lead to vomiting. - Constipation: reduced bowel movements due to decreased gastrointestinal motility. - Drowsiness: increased sleepiness or fatigue. - Itching: mild pruritus, often at the injection site.

Serious or Rare Side Effects: - Respiratory depression: marked slowing of breathing that can be life‑threatening. - Severe hypotension: sudden drop in blood pressure. - Adrenal insufficiency: impaired cortisol production. - Anaphylaxis: acute allergic reaction with potential airway compromise.

Before prescribing morphine, clinicians should consider several safety measures.

- Pain assessment: evaluate intensity and cause before initiating therapy. - Respiratory monitoring: observe breathing rate and oxygen saturation regularly. - Dose adjustment: reduce dose in patients with renal or hepatic impairment. - Concomitant CNS depressants: avoid or use with caution when combined with other sedatives. - Store at ambient temperature: keep in original container, protect from light and moisture.

Morphine can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Other opioids: additive respiratory depression and sedation. - Benzodiazepines: increased risk of profound CNS depression. - MAO inhibitors: risk of severe hypertension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., antihistamines): may enhance drowsiness. - CYP3A4 inhibitors (e.g., erythromycin): can raise morphine plasma levels.